SG126868A1 - Use agomelatine in obtaining medicaments intended for the treatment of bipolar disorders - Google Patents
Use agomelatine in obtaining medicaments intended for the treatment of bipolar disordersInfo
- Publication number
- SG126868A1 SG126868A1 SG200602393A SG200602393A SG126868A1 SG 126868 A1 SG126868 A1 SG 126868A1 SG 200602393 A SG200602393 A SG 200602393A SG 200602393 A SG200602393 A SG 200602393A SG 126868 A1 SG126868 A1 SG 126868A1
- Authority
- SG
- Singapore
- Prior art keywords
- agomelatine
- treatment
- bipolar disorders
- medicaments intended
- obtaining medicaments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0503937A FR2884714B1 (fr) | 2005-04-20 | 2005-04-20 | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG126868A1 true SG126868A1 (en) | 2006-11-29 |
Family
ID=35311309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200602393A SG126868A1 (en) | 2005-04-20 | 2006-04-11 | Use agomelatine in obtaining medicaments intended for the treatment of bipolar disorders |
Country Status (41)
| Country | Link |
|---|---|
| US (1) | US7947743B2 (zh) |
| EP (1) | EP1714647B1 (zh) |
| JP (2) | JP4580364B2 (zh) |
| KR (2) | KR100835451B1 (zh) |
| CN (2) | CN1853619B (zh) |
| AP (1) | AP2656A (zh) |
| AR (1) | AR057277A1 (zh) |
| AT (1) | ATE491443T1 (zh) |
| AU (1) | AU2006201655B2 (zh) |
| BR (1) | BRPI0601285A8 (zh) |
| CA (1) | CA2544136C (zh) |
| CR (1) | CR9426A (zh) |
| CY (1) | CY1111257T1 (zh) |
| DE (1) | DE602006018822D1 (zh) |
| DK (1) | DK1714647T3 (zh) |
| EA (1) | EA013462B1 (zh) |
| ES (1) | ES2357901T3 (zh) |
| FR (1) | FR2884714B1 (zh) |
| GE (1) | GEP20094651B (zh) |
| GT (1) | GT200600141A (zh) |
| HK (1) | HK1093906A1 (zh) |
| HR (1) | HRP20110083T1 (zh) |
| IL (1) | IL186373A (zh) |
| JO (1) | JO2666B1 (zh) |
| MA (1) | MA28266A1 (zh) |
| ME (1) | ME01951B (zh) |
| MY (1) | MY143171A (zh) |
| NO (1) | NO336010B1 (zh) |
| NZ (1) | NZ546630A (zh) |
| PE (1) | PE20061337A1 (zh) |
| PL (1) | PL1714647T3 (zh) |
| PT (1) | PT1714647E (zh) |
| RS (1) | RS51659B (zh) |
| SG (1) | SG126868A1 (zh) |
| SI (1) | SI1714647T1 (zh) |
| TN (1) | TNSN07364A1 (zh) |
| TW (2) | TW200940049A (zh) |
| UA (1) | UA83681C2 (zh) |
| UY (1) | UY29470A1 (zh) |
| WO (1) | WO2006111653A1 (zh) |
| ZA (1) | ZA200603160B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2890563B1 (fr) * | 2005-09-09 | 2007-10-19 | Servier Lab | Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent |
| JP4642134B2 (ja) * | 2007-05-01 | 2011-03-02 | コンサート ファーマシューティカルズ インコーポレイテッド | ナフチル（エチル）アセトアミド |
| FR2978916B1 (fr) * | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
| EP2856934A1 (en) * | 2013-10-04 | 2015-04-08 | Les Laboratoires Servier | Biomarkers for the prediction of long term remission in depression |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5585118A (en) * | 1995-06-02 | 1996-12-17 | Brigham And Women's Hospital | Choline in the treatment of bipolar disorder |
| AU2002242226B2 (en) * | 2001-02-27 | 2006-06-29 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating bipolar disorder |
| FR2834890B1 (fr) * | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'agomelatine |
| AR047553A1 (es) * | 2003-07-04 | 2006-01-25 | Lundbeck & Co As H | La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina |
| US20050164987A1 (en) * | 2003-12-24 | 2005-07-28 | Barberich Timothy J. | Melatonin combination therapy for improving sleep quality |
-
2005
- 2005-04-20 FR FR0503937A patent/FR2884714B1/fr not_active Expired - Fee Related
- 2005-06-01 US US11/142,612 patent/US7947743B2/en not_active Expired - Fee Related
-
2006
- 2006-04-04 JO JO200690A patent/JO2666B1/en active
- 2006-04-04 PE PE2006000362A patent/PE20061337A1/es not_active Application Discontinuation
- 2006-04-07 GT GT200600141A patent/GT200600141A/es unknown
- 2006-04-07 UY UY29470A patent/UY29470A1/es not_active Application Discontinuation
- 2006-04-11 SG SG200602393A patent/SG126868A1/en unknown
- 2006-04-11 UA UAA200604022A patent/UA83681C2/uk unknown
- 2006-04-17 MA MA28940A patent/MA28266A1/fr unknown
- 2006-04-18 NO NO20061705A patent/NO336010B1/no not_active IP Right Cessation
- 2006-04-19 KR KR1020060035392A patent/KR100835451B1/ko not_active IP Right Cessation
- 2006-04-19 EA EA200600600A patent/EA013462B1/ru not_active IP Right Cessation
- 2006-04-19 ME MEP-2011-231A patent/ME01951B/me unknown
- 2006-04-19 NZ NZ546630A patent/NZ546630A/en not_active IP Right Cessation
- 2006-04-19 AT AT06290636T patent/ATE491443T1/de active
- 2006-04-19 PL PL06290636T patent/PL1714647T3/pl unknown
- 2006-04-19 WO PCT/FR2006/000859 patent/WO2006111653A1/fr active Application Filing
- 2006-04-19 GE GEAP20069356A patent/GEP20094651B/en unknown
- 2006-04-19 TW TW098118938A patent/TW200940049A/zh unknown
- 2006-04-19 AR ARP060101537A patent/AR057277A1/es not_active Application Discontinuation
- 2006-04-19 SI SI200630921T patent/SI1714647T1/sl unknown
- 2006-04-19 DE DE602006018822T patent/DE602006018822D1/de active Active
- 2006-04-19 EP EP06290636A patent/EP1714647B1/fr active Active
- 2006-04-19 RS RS20110110A patent/RS51659B/en unknown
- 2006-04-19 DK DK06290636.7T patent/DK1714647T3/da active
- 2006-04-19 MY MYPI20061783A patent/MY143171A/en unknown
- 2006-04-19 AP AP2007004212A patent/AP2656A/xx active
- 2006-04-19 ES ES06290636T patent/ES2357901T3/es active Active
- 2006-04-19 PT PT06290636T patent/PT1714647E/pt unknown
- 2006-04-19 TW TW095113952A patent/TWI318115B/zh not_active IP Right Cessation
- 2006-04-20 BR BRPI0601285A patent/BRPI0601285A8/pt not_active IP Right Cessation
- 2006-04-20 AU AU2006201655A patent/AU2006201655B2/en not_active Ceased
- 2006-04-20 CA CA2544136A patent/CA2544136C/fr not_active Expired - Fee Related
- 2006-04-20 ZA ZA200603160A patent/ZA200603160B/en unknown
- 2006-04-20 JP JP2006116294A patent/JP4580364B2/ja not_active Expired - Fee Related
- 2006-04-20 CN CN2006100764985A patent/CN1853619B/zh not_active Expired - Fee Related
- 2006-04-20 CN CN2010105781057A patent/CN102038669A/zh active Pending
-
2007
- 2007-01-10 HK HK07100339.3A patent/HK1093906A1/xx not_active IP Right Cessation
- 2007-09-26 TN TNP2007000364A patent/TNSN07364A1/en unknown
- 2007-10-07 IL IL186373A patent/IL186373A/en not_active IP Right Cessation
- 2007-10-08 CR CR9426A patent/CR9426A/es not_active Application Discontinuation
-
2008
- 2008-02-29 KR KR1020080018845A patent/KR20080028389A/ko not_active Application Discontinuation
-
2010
- 2010-08-06 JP JP2010177003A patent/JP5341037B2/ja not_active Expired - Fee Related
-
2011
- 2011-02-02 HR HR20110083T patent/HRP20110083T1/hr unknown
- 2011-02-23 CY CY20111100222T patent/CY1111257T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1100481A1 (en) | Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient | |
| HK1170429A1 (zh) | 用於治療認知障礙的α-氨基酰胺衍生物 | |
| IL184425A0 (en) | Cxcr4 antagonists for the treatment of medical disorders | |
| IL185462A0 (en) | New pharmaceutical compositions useful in the treatment of pain | |
| IL178775A (en) | Pharmaceuticals containing glucocorticoid for use in the treatment of disorders requiring acute glucocorticoid therapy | |
| ZA200801667B (en) | Novel pharmaceutical combinations for the treatment of respiratory disorders | |
| AP2488A (en) | Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder | |
| LT1807156T (lt) | Naujos farmacinės kompozicijos, naudingos nemigos gydyme | |
| GB2442365B (en) | Methods of determining compounds useful in the treatment of bipolar disorders | |
| AP2656A (en) | Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders | |
| GB0710277D0 (en) | Use of antivirals in the treatment of medical disorders | |
| TWI370735B (en) | Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndrome | |
| IL188104A (en) | Use of intravenous mixtures of valenoctamide to prepare drugs for the treatment of bipolar disorders | |
| IL182406A0 (en) | Use of an anti-atherothrombotic compound in obtaining medicaments intended for the treatment of vascular disorders | |
| HK1125634A1 (en) | Pharmaceutical for use in the treatment of ureterolithiasis | |
| IL194275A0 (en) | Use of digitalis-like compounds in the treatment of affective disorders | |
| SI2030622T1 (sl) | Indikacija odmerka progesterona pri zdravljenju travmatske poškodbe možganov |